| Medical and Health Sciences | Lifetime | 523 | CA 28 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 85 | CA 5 | 99.98 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 44 | CA 2 | 99.85 |
| Cardiology and Cardiovascular Medicine | Lifetime | 268 | CA 17 | 99.65 |
| Surgery | Lifetime | 592 | CA 31 | 99.45 |
| Epidemiology | Lifetime | 620 | CA 26 | 99.22 |
| Medical Physiology | Lifetime | 691 | CA 40 | 98.79 |
| Pulmonary and Respiratory Medicine | Lifetime | 901 | CA 49 | 98.53 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 13 | CA 1 | 99.92 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 85 | CA 3 | 99.64 |
| Surgery | 2021-2025 | 156 | CA 10 | 99.08 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 787 | CA 32 | 89.68 |
| Diabetes Treatment and Management | Lifetime | 20 | CA 5 | 99.85 |
| Pancreatic function and diabetes | Lifetime | 108 | CA 5 | 99.54 |
| Cardiovascular Function and Risk Factors | Lifetime | 183 | CA 9 | 99.63 |
| Metabolism, Diabetes, and Cancer | Lifetime | 98 | CA 8 | 99.50 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 102 | CA 1 | 99.40 |
| Heart Failure Treatment and Management | Lifetime | 147 | CA 10 | 99.41 |
| Nitric Oxide and Endothelin Effects | Lifetime | 174 | CA 8 | 99.15 |
| Diet, Metabolism, and Disease | Lifetime | 172 | CA 8 | 98.94 |
| Aortic Disease and Treatment Approaches | Lifetime | 181 | CA 9 | 99.02 |
| Cardiac Valve Diseases and Treatments | Lifetime | 393 | CA 22 | 99.17 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 180 | CA 7 | 98.55 |
| Cardiovascular Disease and Adiposity | Lifetime | 264 | CA 10 | 98.55 |
| Pharmacology and Obesity Treatment | Lifetime | 132 | CA 8 | 98.39 |
| Cardiovascular Health and Disease Prevention | Lifetime | 351 | CA 8 | 98.29 |
| Aortic aneurysm repair treatments | Lifetime | 305 | CA 7 | 98.16 |
| Peripheral Artery Disease Management | Lifetime | 318 | CA 10 | 97.89 |
| Angiogenesis and VEGF in Cancer | Lifetime | 360 | CA 8 | 97.75 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 357 | CA 22 | 98.32 |
| Lipoproteins and Cardiovascular Health | Lifetime | 429 | CA 30 | 98.21 |
| Cardiac and Coronary Surgery Techniques | Lifetime | 255 | CA 28 | 97.59 |
| Potassium and Related Disorders | Lifetime | 109 | CA 7 | 97.65 |
| Cardiac Ischemia and Reperfusion | Lifetime | 408 | CA 20 | 97.46 |
| Diabetes Management and Research | Lifetime | 719 | CA 25 | 97.70 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 662 | CA 37 | 97.58 |
| Infectious Aortic and Vascular Conditions | Lifetime | 502 | CA 15 | 92.91 |
| Apelin-related biomedical research | Lifetime | 453 | CA 21 | 90.19 |
| Cardiac Fibrosis and Remodeling | Lifetime | 938 | CA 33 | 89.88 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 5 | CA 1 | 99.78 |
| Diabetes Treatment and Management | 2021-2025 | 14 | CA 1 | 99.88 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 30 | CA 1 | 99.77 |
| Pancreatic function and diabetes | 2021-2025 | 18 | CA 2 | 99.45 |
| Heart Failure Treatment and Management | 2021-2025 | 49 | CA 2 | 99.55 |
| Diet and metabolism studies | 2021-2025 | 257 | CA 11 | 97.08 |
| Peripheral Artery Disease Management | 2021-2025 | 144 | CA 7 | 95.33 |
| Pharmacology and Obesity Treatment | 2021-2025 | 41 | CA 3 | 96.22 |
| Diabetes Management and Research | 2021-2025 | 266 | CA 8 | 96.61 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 245 | CA 15 | 94.41 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 98 | CA 6 | 86.74 |
| Hormonal Regulation and Hypertension | 2021-2025 | 389 | CA 13 | 88.68 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 635 | CA 15 | 85.30 |
| Apelin-related biomedical research | 2021-2025 | 62 | CA 1 | 82.28 |
| Potassium and Related Disorders | 2021-2025 | 154 | CA 8 | 87.09 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 826 | CA 25 | 85.31 |
| Lipid metabolism and disorders | 2021-2025 | 359 | CA 21 | 76.07 |
| Electrolyte and hormonal disorders | 2021-2025 | 520 | CA 18 | 70.88 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 503 | CA 22 | 67.36 |
| Cardiac and Coronary Surgery Techniques | 2021-2025 | 989 | CA 41 | 61.52 |